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CORRESPONDENCE
Re: ‘Type II Endoleak: Conservative Management Is a Safe
Strategy’
Sidloff et al.1 report an improved overall mortality among
patients with type 2 endoleaks. However, their conclusions
must be interpreted with caution as study design and
consequent selection bias are limiting factors. Moreover, a
causal connection between type 2 endoleaks and improved
survival is implausible and most likely the effect of con-
founders. Although a lower atherosclerotic burden in these
patients has been reported,2 this hypothesis does not ﬁnd
support in the presented data.
Type 2 endoleaks have been associated with occult or
posture dependent type 1 and type 3 endoleaks,3,4 suture line
holes,5 or late fabric failure,6 which lead to outﬂow of blood
from the sac to its’main collaterals. In their cohort, Sidloff et al.
reported six cases of type 1 endoleak among the type 2
endoleak group, which was not statistically signiﬁcant. Never-
theless, although angiography has been demonstrated to be
more discriminating for the diagnosis of occult type 1 or 3
endoleaks,4 it was not routinely performed in the study group.
Type 2 endoleak directed interventions have proven to be
ineffective in arresting aneurysm sac enlargement,7 and
treatment related complications have probably been under
reported in the literature.8 In the cohort presented by Sidloff
et al., interventions were also unsuccessful,1 but the authors’
treatment strategy is not clearly presented. Moreover, data
regarding aneurysm sac dynamics following treatment could
have further elucidated the outcomes of these interventions.
The bottom line is the natural history of type 2 endoleaks
is not clear, their impact on aneurysm related adverse events
is controversial, and optimal management remains to be
established. Moreover, although attempts to resolve type 2
endoleaks remain largely unsuccessful, type 2 endoleaks are
at least associated with an equivalent overall prognosis.
Perhaps, this may be further improved if the consequences
of unnecessary interventions are avoided.
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Re: ‘Type II Endoleak: Conservative Management Is a Safe
Strategy’
Thank you for your interest in this article. An association
between type II endoleak and survival has recently been
described in a similar cohort of patients1; therefore, this
ﬁnding is not unique. We acknowledge that these obser-
vations are unexplained, and possibly secondary to con-
founders, but do not feel that they can be dismissed
without further investigation in independent studies.
Furthermore, we feel that whilst interesting, this ﬁnding is not
the key take-home message from our work, and in-depth
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discussionwithout further evidence detracts fromour principal
ﬁnding that in our large cohort of patients the conservative
management of patients with isolated type II endoleak has not
resulted in an increased aneurysm-related mortality, or the
development of high-pressure endoleaks. We have also
demonstrated that whilst angiography may be more discrimi-
native for thediagnosis ofoccult type1or 3 endoleaks, its use in
patientswith type II endoleakwithout signiﬁcant sac expansion
may carry more risk then beneﬁt. Importantly, in our paper we
have demonstrated that over half of all type II endoleaks
spontaneously resolve without intervention.
We agree that a gold standard strategy for managing
patients with type II endoleak remains to be established. It
is unlikely that a randomised controlled trial comparing
different treatment strategies will be possible so the setting
up of a multicentre type II endoleak registry to formally
compare different approaches is imperative.
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Re: ‘‘Spontaneous Delayed Sealing in Selected Patients
With a Primary Type Ia Endoleak After Endovascular
Aneurysm Repair.’ Does Correcting the Picture Save the
Life?’
I read the paper by Gonçalves et al. with interest.1 The
authors state that, in selected patients, a conservative
approach for primary type Ia endoleak may be justiﬁed. All
but one of the 15 primary type Ia endoleaks sealed spon-
taneously within 5 months. The disappearance of type Ia
endoleaks resulted from improved graft wall apposition due
to neck remodelling or thrombosis of the non-apposed neck
segment.
If the barrier between the aneurysm sac and the sys-
temic arterial circulation consists of thrombus only, sys-
temic pressure can be transmitted through a clot, and it is
known that mural thrombus on the surface of the aneu-
rysm sac does not prevent rupture.2 For this reason, a
thrombotic barrier on the neck segment may eliminate
type Ia endoleak but may not prevent rupture. In the
presented study, although ruptures were not detected in
the 14 patients, sac growth occurred in four (28.5%).1 In
these patients known causes of sac growth were not
detected by CT. There are limited data about the long-
term results of the other methods of induction of
thrombosis on the non-apposed neck segment, such as
ﬁbrin glue injection or coil embolization. Feng et al.3
documented results of patients treated by ﬁbrin glue in-
jection: one aneurysm related death and four aneurysm
sac growths were detected in 48 cases during 45 months
follow up.
Until the long-term results are clearer, we should avoid a
conservative or similar approaches to induce thrombus
formation for treatment of type I endoleak. Correcting the
picture may not save the life.
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